Three core CSF biomarkers, e.g. Amyloid-ß42 (Aß42), total tau (t-tau) and phosphorylated tau (p-tau) proteins, have been included in the diagnostic criteria of AD, and could be relevant for differential diagnosis [3]. Here, MAPT is linked to Alzheimer disease.